Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - Arch Therapeutics, Inc.Financial_Report.xls
10-K - Arch Therapeutics, Inc.g6510.txt
XML - IDEA: XBRL DOCUMENT - Arch Therapeutics, Inc.R9.htm
XML - IDEA: XBRL DOCUMENT - Arch Therapeutics, Inc.R3.htm
XML - IDEA: XBRL DOCUMENT - Arch Therapeutics, Inc.R7.htm
XML - IDEA: XBRL DOCUMENT - Arch Therapeutics, Inc.R8.htm
XML - IDEA: XBRL DOCUMENT - Arch Therapeutics, Inc.R5.htm
XML - IDEA: XBRL DOCUMENT - Arch Therapeutics, Inc.R2.htm
XML - IDEA: XBRL DOCUMENT - Arch Therapeutics, Inc.R1.htm
XML - IDEA: XBRL DOCUMENT - Arch Therapeutics, Inc.R4.htm
XML - IDEA: XBRL DOCUMENT - Arch Therapeutics, Inc.R10.htm
XML - IDEA: XBRL DOCUMENT - Arch Therapeutics, Inc.R26.htm
XML - IDEA: XBRL DOCUMENT - Arch Therapeutics, Inc.R16.htm
XML - IDEA: XBRL DOCUMENT - Arch Therapeutics, Inc.R22.htm
XML - IDEA: XBRL DOCUMENT - Arch Therapeutics, Inc.R12.htm
XML - IDEA: XBRL DOCUMENT - Arch Therapeutics, Inc.R24.htm
XML - IDEA: XBRL DOCUMENT - Arch Therapeutics, Inc.R25.htm
XML - IDEA: XBRL DOCUMENT - Arch Therapeutics, Inc.R19.htm
XML - IDEA: XBRL DOCUMENT - Arch Therapeutics, Inc.R17.htm
XML - IDEA: XBRL DOCUMENT - Arch Therapeutics, Inc.R15.htm
XML - IDEA: XBRL DOCUMENT - Arch Therapeutics, Inc.R14.htm
XML - IDEA: XBRL DOCUMENT - Arch Therapeutics, Inc.R11.htm
XML - IDEA: XBRL DOCUMENT - Arch Therapeutics, Inc.R23.htm
XML - IDEA: XBRL DOCUMENT - Arch Therapeutics, Inc.R21.htm
XML - IDEA: XBRL DOCUMENT - Arch Therapeutics, Inc.R27.htm
XML - IDEA: XBRL DOCUMENT - Arch Therapeutics, Inc.R18.htm
XML - IDEA: XBRL DOCUMENT - Arch Therapeutics, Inc.R13.htm
EX-32.1 - Arch Therapeutics, Inc.ex32-1.txt
EX-31.1 - Arch Therapeutics, Inc.ex31-1.txt
XML - IDEA: XBRL DOCUMENT - Arch Therapeutics, Inc.R20.htm
v2.4.0.6
ALMAH,INC - (A Development Stage Company) - Statements of Cash Flows (USD $)
12 Months Ended 36 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Sep. 30, 2012
Cash Flows from Operating Activities      
Net (Loss) $ (36,611) $ (5,037) $ (41,648)
Changes in operating Assets and Liabilities      
Increase (Decrease) in Prepaid Expenses (151) (99) (250)
Increase (Decrease) in Accounts Payable 25 0 25
Increase (Decrease) in Accrued Expenses 2,980 3,000 5,980
Net Cash Used in Operating Activities (33,757) (2,136) (35,893)
Cash Flows from Financing Activities      
Note Payable - Related Party 0 60 61
Proceeds from Sale of Common Stock 20,300 20,000 40,300
Net Cash Provided by Financing Activities 20,300 20,061 40,361
Net Increase (Decrease) in Cash and Cash Equivalents (13,457) 17,925 4,468
Cash and Cash Equivalents at Beginning of Period 17,925 0 0
Cash and Cash Equivalents at End of Period 4,468 17,925 4,468
Supplemental Diclosures of Cash Flow Information      
Cash Paid During Year for Interest 0 0 0
Cash Paid During Year for Income Taxes $ 0 $ 0 $ 0